Top Diseases Stories


Comment & Analysis »

GlobalData Healthcare

Roche’s Ocrevus expected to be a game-changer for the multiple sclerosis market

On 28 March, the FDA approved Roche’s pipeline asset, Ocrevus (ocrelizumab), for multiple sclerosis (MS) after a three-month delay....

Roche’s Ocrevus expected to be a game-changer for the multiple sclerosis market
GlobalData Healthcare

Move Over, Zika and Ebola - the next global epidemic could be metabolic

Move Over, Zika and Ebola - the next global epidemic could be metabolic
GlobalData Healthcare

Antibiotic stewardship: can we learn from England’s C. difficile success?

Antibiotic stewardship: can we learn from England’s C. difficile success?
GlobalData Healthcare

Pfizer seeking a timely re-launch of Mylotarg in AML amid increasing competition

Pfizer seeking a timely re-launch of Mylotarg in AML amid increasing competition
GlobalData Healthcare

Rare diseases are a huge opportunity for pharma

Rare diseases are a huge opportunity for pharma

Company Releases »

Contamination Control Floor Solutions

Dycem
Contamination Control Floor Solutions

Chambers and Testing Rooms for Maintaining Temperature and Humidity

Aralab
Chambers and Testing Rooms for Maintaining Temperature and Humidity

Contamination Control

Dycem Contamination Control

Testing Parenteral Products for Micro Leaks, Container Closure Integrity Test

PTI - Packaging Inspection Systems
Testing Parenteral Products for Micro Leaks, Container Closure Integrity Test

Effluent and Carcass Sterilization and Disposal System

PRI Bio Effluent and Carcass Sterilization and Disposal System

Diseases Insights »

Companies »